N. J. O’Higgins
Researcher Next ID · RN-040688
Researcher · Biochemistry, Genetics and Molecular Biology
Dublin, Ireland
- Works count
- 329
- Citation count
- 9,094
- H-index
- 56
- i10-index
- 127
Research interests
Publications
Intraoperative margin assessment and re-excision rate in breast conserving surgery
European Journal of Surgical Oncology · 2003 · 10.1016/j.ejso.2003.11.008
Prognostic importance of survivin in breast cancer
British Journal of Cancer · 2003 · https://doi.org/10.1038/sj.bjc.6600776
Caspase 3 in breast cancer.
PubMed · 2003
Expression of ADAM‐9 mRNA and protein in human breast cancer
International Journal of Cancer · 2003 · 10.1002/ijc.11161
Caspase 3 in breast cancer.
PubMed · 2003
Expression of ADAM‐9 mRNA and protein in human breast cancer
International Journal of Cancer · 2003 · 10.1002/ijc.11161
Intraoperative margin assessment and re-excision rate in breast conserving surgery
European Journal of Surgical Oncology · 2003 · 10.1016/j.ejso.2003.11.008
Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients
JNCI Journal of the National Cancer Institute · 2002 · https://doi.org/10.1093/jnci/94.2.116
CA 15–3: A Prognostic Marker in Breast Cancer
The International Journal of Biological Markers · 2000 · 10.1177/172460080001500410
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
Breast Cancer Research · 2000 · 10.1186/bcr65
CA 15–3: A Prognostic Marker in Breast Cancer
The International Journal of Biological Markers · 2000 · 10.1177/172460080001500410
Urokinase plasminogen activator: A prognostic marker in multiple types of cancer
Journal of Surgical Oncology · 1999 · 10.1002/(sici)1096-9098(199906)71:2<130::aid-jso14>3.0.co;2-9
High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer
International Journal of Cancer · 1999 · 10.1002/(sici)1097-0215(19990219)84:1<44::aid-ijc9>3.0.co;2-p
High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer
International Journal of Cancer · 1999 · 10.1002/(sici)1097-0215(19990219)84:1<44::aid-ijc9>3.0.co;2-p
Urokinase plasminogen activator: A prognostic marker in multiple types of cancer
Journal of Surgical Oncology · 1999 · 10.1002/(sici)1096-9098(199906)71:2<130::aid-jso14>3.0.co;2-9
Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer
Annals of Oncology · 1998 · 10.1023/a:1008226721932
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
International Journal of Cancer · 1995 · 10.1002/ijc.2910610502
Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer
International Journal of Cancer · 1995 · 10.1002/ijc.2910610502
Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.
PubMed · 1990
Current projects
No projects listed.